Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer

Journal of Epidemiology and Community Health

Volumn 53, Issue 11, 1999, Pages 702-709

  Porta, Miquel ^a,g   Malats, Núria ^a   Guarner, Luisa ^b   Carrato, Alfredo ^c   Rifà, Juli ^d   Salas, Antonio ^e   Corominas, Josep M ^f   Andreu, Montserrat ^f   Real, Franscisco X ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^d HOSPITAL SON DURETA   (Spain)

^e HOSPITAL MÚTUA DE TERRASSA   (Spain)

^f HOSPITAL DEL MAR   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CAFFEINE; CELL DNA;

ADULT; AGE; AGED; ARTICLE; CANCER GENETICS; CODON; COFFEE; DOSE RESPONSE; DRINKING BEHAVIOR; FEMALE; GENE ACTIVATION; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PANCREAS CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX; SMOKING; SPAIN;

EID: 0032875512     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.53.11.702     Document Type: Article

References (70)

1. International Agency for Research on Cancer. IARC Monographs of the evaluation of carcinogenic risks to humans. Vol. 51. Coffee, tea, mate, methylxanthines and methylglyoxal. Lyon: International Agency for Research on Cancer, 1991:36-7, 52-7, 92, 167-74.
2. Mohr U, Emura M, Riebe-Imre M. Experimental studies on carcinogenicity and mutagenicity of caffeine. In: Garattini S, ed. Caffeine, coffee, and health. New York: Raven, 1993:359-78.
3. Reddy CS, Hayes AW. Food-borne toxicants. In: Hayes AW, ed. Principles and methods of toxicology. 3rd ed. New York: Raven, 1994:317-60.
4. Dews PB, ed. Caffeine. Perspectives from recent research. Berlin: Springer, 1984.
5. Murnane JP. Cell cycle regulation in response to DNA damage in mammalian cells: a historical perspective. Cancer Metastasis Rev 1995;14:17-29.
6. Howe GR, Burch JD. Nutrition and pancreatic cancer. Cancer Causes Control 1996;7:69-82.
7. Potter JD, ed. Food, nutrition and the prevention of cancer: a global perspective. Washington: American Institute for Cancer Research and World Cancer Research Fund, 1997:176-97, 467-71.
8. La Vecchia C. Coffee and cancer epidemiology. In: Garattini S, ed. Caffeine, coffee, and health. New York: Raven, 1993:379-98.
9. Silverman DT, Swanson CA, Gridley G, et al. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst 1998;90:1710-19.
10. Gordis L. Consumption of methylxanthine-containing beverages and risk of pancreatic cancer. Cancer Lett 1990;52:1-12.
11. Lyon JL, Mahoney AW, French TK, et al. Coffee consumption and cancer of the exocrine pancreas: a case-control study in a low-risk population. Epidemiology 1992;3:164-70.
12. Gullo L, Pezzilli R, Morselli-Labate AM. Coffee and cancer of the pancreas: an Italian multicenter study. Pancreas 1995;11:223-9.
13. Nishi M, Ohba S, Hirata K, et al. Dose-response relationship between coffee and the risk of pancreas cancer. Jpn J Clin Oncol 1996;26:42-8.
14. Harnack LJ, Anderson KE, Zheng W, et al. Smoking, alcohol, coffee, and tea intake and incidence of cancer of the exocrine pancreas: The Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 1997;6:1081-6.
15. Weiderpass E, Partanen T, Kaaks R, et al. Occurrence, trends and environmental etiology of pancreatic cancer. Scand J Work Environ Health 1998;24:165-74.
16. Gold EB. Epidemiology of and risk factors for pancreatic cancer. Surg Clin North Am 1995;75:819-43.
17. Anderson KE, Potter JD, Mack TM. Pancreatic cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. 2nd ed. New York: Oxford University Press, 1996:725-71.
18. Taylor JA. Oncogenes and their applications in epidemiologic studies. Am J Epidemiol 1989;130:6-13.
19. Vineis P, Porta M. Causal thinking, biomarkers and mechanisms of carcinogenesis. J Clin Epidemiol 1996;49:951-6.
20. Vineis P, Malats N, Porta M, et al. Human cancer, carcinogenic exposures and mutational spectra. Mutat Res 1999;436:185-94.
21. Toniolo P, Boffetta P, Shuker DEG, et al, eds. Application of biomarkers in cancer epidemiology. IARC Scientific publications, no 142. Lyon: International Agency for Research on Cancer, 1997.
22. Rothman N, Stewart WF, Schulte PA. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Cancer Epidemiol Biomarkers Prev 1995;4:301-11.
23. Caldas C, Kern SE. K-ras mutation and pancreatic adenocarcinoma. Int J Pancreatol 1995;18:1-6.
24. Real FX. The cell biology of pancreatic cancer. In: Neoptolemos J, Lemoine NR, eds. Pancreatic cancer. Molecular and clinical advances. London: Blackwell, 1995:3-17.
25. Porta M, Real FX, Malats N, et al. Role of mutations in K-ras and p53 genes in exocrine pancreatic cancer and cancer of the biliary tract (PANKRAS II). In: Sankaranarayanan R, Wahrendorf J, Démaret E, eds. Directory of on-going research in cancer epidemiology 1996. IARC Scientific publications, no 137. Lyon: International Agency for Research on Cancer, 1996:304.
26. Porta M, Real FX, Malats N, et al. Estudio Multicéntrico Prospectivo sobre el Papel del Oncogen K-ras y del Gen p53 en el Diagnóstico, el Pronóstico y la Etiologia del Cáncer de Páncreas Exocrino y en el Cancer de las Vias Biliares (PANKRAS II) [Multicentre Prospective Study on the Role of K-ras Oncogene and p53 Gene in the Diagnosis, Prognosis and Etiology of Exocrine Pancreatic Cancer and Cancer of the Biliary Tract]. Fondo de Investigación Sanitaria (FIS) project #92/0007. Madrid: Fondo de Investigación Sanitaria, Ministry of Health; 1991.
27. Malats N, Porta M, Fernandez E, et al. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. [Letter]. J Natl Cancer Inst 1994;86: 1353-54.
28. Porta M, Malats N, Piñol JL, et al. Relevance of misclassification of disease status in epidemiologic studies of exocrine pancreatic cancer. [Letter]. J Clin Epidemiol 1996;49:602-3.
29. Malats N, Real FX, Porta M. DDT and pancreatic cancer. [Letter]. J Natl Cancer Inst 1993;85:328-9.
30. Soler M, Porta M, Malats N, et al. Learning from case-reports: diagnostic issues in an epidemiologic study of pancreatic cancer. J Clin Epidemiol 1998;51: 1215-21.
31. International Union Against Cancer. TNM classification of malignant tumours. 4th ed, 2nd rev. Berlin: Springer, 1992.
32. American Joint Committee on Cancer, TNM Committee of the International Union Against Cancer. Handbook for staging of cancer from the Manual for Staging of Cancer. 4th ed. Philadelphia: J B Lippincott, 1993.
33. World Health Organization. International classification of diseases for oncology (ICD-O-2). 2nd ed. Geneva: World Health Organization, 1990.
34. Berg JW. Morphologic classification of human cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. 2nd ed. New York: Oxford University Press, 1996:28-44.
35. Escolar A, Gonzalez CA, López-Abente G, et al. Bladder cancer and coffee consumption in smokers and non-smokers in Spain. Int J Epidemiol 1993;22:38-44.
36. López-Abente G, González CA, Errezola M, et al. Tobacco smoke inhalation pattern, tobacco type, and bladder cancer in Spain. Am J Epidemiol 1991;134:830-9.
37. Gavaldà L, Porta M, Malats N, et al. Concordancia entre la información facilitada por el paciente y un familiar sobre antecedentes patológicos, consumo de tabaco, de alcohol, de café, y dieta en el cáncer de páncreas exocrino y del sistema biliar extrahepático. Gac Sanit 1995;9: 334-42.
38. Berrozpe G, Schaeffer J, Peinado MA, et al. Comparative analysis of mutations in p53 and Ki-ras genes in pancreas cancer. Int J Cancer 1994;58:185-91.
39. Malats N, Porta M, Piñol JL, et al. Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. J Clin Oncol 1995;13:1679-86.
40. Malats N, Porta M, Corominas JM, et al. Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. Int J Cancer 1997;70:661-7.
41. Piegorsch WW, Weinberg CR, Taylor JA. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med 1994;13:153-62.
42. Begg CB, Zhang Z-F. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 1994;3:173-5.
43. Armitage P, Berry G. Statistical methods in medical research. 3rd ed. Oxford: Blackwell, 1994.
44. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research. Principles and quantitative methods. Belmont (CA): Lifetime Learning Publications, 1982:320-76, 419-56.
45. Breslow NE, Day NE. Statistical methods in cancer research. Vol I: The analysis of case-control studies. Lyon: IARC Scientific Publications, 1980:149-54.
46. Yang M, Kawamoto T, Katoh T, et al. Effects of lifestyle and genetic polymorphisms on consumption of coffee or black tea and urinary caffeine levels. Biomarkers 1998;3: 367-77.
47. Rozenblum E, Schutte M, Goggins M, et al. Tumor-suppresive pathways in pancreatic carcinoma. Cancer Res 1997;57:1731-34.
48. Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997;57:2140-3.
49. Mulcahy HE, Lyautey J, Lederrey C, et al. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res 1998;4:271-5.
50. Terhune PG, Phifer DM, Tosteson TD, et al. K-ras mutation in focal proliferative lesions of human pancreas. Cancer Epidemiol Biomarkers Prev 1998;7:515-21.
51. Tada M, Ohashi M, Shiratori Y, et al. Analysis of K-ras gene mutations in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996;110:227-31.
52. Agapova LS, Ilyinskaya GV, Turovets NA, et al. Chromosome changes caused by alterations of p53 expression. Mutat Res 1996;354:129-38.
53. DeFrank JS, Tang W, Powell SN. p53-null cells are more sensitive to ultraviolet light only in the presence of caffeine. Cancer Res 1996;56:5365-8.
54. Muller WU, Bauch T, Wojcik A, et al. Comet assay studies indicate that caffeine-mediated increase in radiation risk of embryos is due to inhibition of DNA repair. Mutagenesis 1996;11:57-60.
55. Efferth TH, Fabry U, Glatte P, et al. Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells. J Cancer Res Clin Oncol 1995;121:648-56.
56. Link CJ Jr, Evans MK, Cook JA, et al. Caffeine inhibits gene-specific repair of UV-induced DNA damage in hamster cells and in human xeroderma pigmentosum group C cells. Carcinogenesis 1995;16:1149-55.
57. Viani R. The composition of coffee. In: Garattini S, ed. Caffeine, coffee, and health. New York: Raven, 1993:17-41.
58. Tomatis L, Aitio A, Day NE, et al, eds. Cancer: causes, occurrence and control. IARC Scientific publications, 100. Lyon: International Agency for Research on Cancer, 1990: 214-5.
59. Garattini S. Overview. In: Garattini S, ed. Caffeine, coffee, and health. New York: Raven, 1993:399-403.
60. Falk RT, Pickle LW, Fontham ET, et al. Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol 1988;128:324-36.
61. Schreiber GB, Robins M, Maffeo CE, et al. Confounders contributing to the reported associations of coffee or caffeine with disease. Prev Med 1988;17:295-309.
62. Colston KW, James SY, Ofori-Kuragu EA, et al. Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer 1997;76:1017-20.
63. Maclure M, Greenland S. Tests for trend and dose response: misinterpretations and alternatives. Am J Epidemiol 1992; 135:96-104.
64. D'Amicis A, Viani R. The consumption of coffee. In: Garattini S, ed. Caffeine, coffee, and health. New York: Raven, 1993:1-16.
65. Schreiber GB, Maffeo CE, Robins M, et al. Measurement of coffee and caffeine intake: implications for epidemiologic research. Prev Med 1988;17:280-94.
66. James JE, Bruce MS, Lader MH, et al. Self-report reliability and symptomatology of habitual caffeine consumption. Br J Clin Pharmacol 1989;27:507-14.
67. Kennedy JS, von Moltke LL, Harmatz JS, et al. Validity of self-reports of caffeine use. J Clin Pharmacol 1991;31: 677-80.
68. D'Avanzo B, La Vecchia C, Katsouyanni K, et al. Reliability of information on cigarette smoking and beverage consumption provided by hospital controls. Epidemiology 1996;7:312-15.
69. Barone JJ, Roberts H. Human consumption of caffeine. In: Dews PB, ed. Caffeine. Perspectives from recent research. Berlin: Springer, 1984:59-73.
70. Bolúmar F, Olsen J, Rebagliato M, et al. Caffeine intake and delayed conception: a European multicenter study on infertility and subfecundity. Am J Epidemiol 1997;145:324-34.